RASP Rasna Therapeutics

Rasna Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.